Navigation Links
Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products
Date:1/18/2011

LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011 /PRNewswire/ -- Fenwal, Inc. of Lake Zurich, Illinois, and GenesisBPS of Hackensack, N.J., announced today they have signed an agreement under which Fenwal will co-market and distribute a range of Genesis-branded products for blood centers, plasma centers and hospitals in the United States and Canada.

The agreement covers products such as Genesis™ blood collection mixers and monitors, RapidSeal II™ tube sealers and automated plasma expressers. Genesis products are designed to help operators improve precision and accuracy in the collection, separation, preparation and storage of blood components.

Fenwal is a global medical technology company focused on improving blood collection, separation, safety and availability. It offers the broadest range of technologies and supplies used in blood collection and transfusion medicine.

"This agreement further expands the Fenwal product offering and enhances the value we bring blood and plasma centers in North America," said Dean Gregory, Fenwal senior vice president of Commercial Operations.

"Fenwal brings high standards for service excellence and extensive knowledge in serving blood and plasma centers," said Adam Grossman, executive vice president of GenesisBPS. "Customers will benefit from the enhanced support and one-stop convenience this partnership creates."

Fenwal will exclusively market and distribute GenesisBPS products to community blood centers and plasma collection centers. GenesisBPS will market and distribute direct to the American Red Cross and U.S. government organizations, and both companies will service hospital accounts.

About Fenwal

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experience and commitment to transfusion medicine. The company offers the broadest range of products for the automated and manual collection of blood and blood components. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used to help treat patients on six continents. Fenwal, Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

About GenesisBPS

GenesisBPS provides a complete range of blood specialty products designed to meet the unique and demanding needs of blood collection and processing organizations worldwide. The company focuses on the collection, processing, storage and preparation of blood, blood components and fluids. The Genesis product line includes Genesis™ Blood Collection Mixers and Monitors, Rapid-Seal II™ Tube Sealers, the TCD™ Sterile Tube Welder, PedI-Pak™ pediatric transfusion products, as well as a complete line of ancillary products and supplies. GenesisBPS is based in Hackensack, N.J. For more information, please visit www.genesisbps.com.


'/>"/>
SOURCE Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Papastavros Opens New Radiology Centers in Delaware
2. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
3. Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology
4. Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America
5. Saints Medical Center and ZOLL Medical Corporation Enter Collaborative Agreement
6. The Center for Business Intelligence (CBI) Announces Virtual Conference on Imaging for Drug Development
7. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
8. New URAC Program to Guide Practices as They Transform Themselves into Patient Centered Health Care Homes Now Available
9. Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector
10. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
11. InfraReDx Awarded 2010 Tax Incentive From Massachusetts Life Sciences Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):